Research in the Journal of Clinical Endocrinology and Metabolism has demonstrated that combined GH and testosterone administration produces greater improvements in lean mass and fat reduction than either hormone alone
(2023) used microdialysis to identify 26 interstitial muscle proteins associated with these pathways, with most proteins being downregulated
Subsequent exposure of BPC157-exposed fibroblasts to growth hormone produced time-dependent increases in cellular proliferation, quantified by MTT assay and PCNA expression analysis
Gross necropsy and histopathologic examination found no organ damage in liver, spleen, lung, kidney, brain, thymus, prostate, ovaries, or gastric wall
The FDA-approved schedule starts low and increases by 2.5 mg every four weeks